PDF(1057 KB)
乳糖酶添加剂对早产儿乳糖不耐受有效性和安全性的前瞻性随机对照研究
王丽, 王依闻, 谭金童, 严洁, 吴燕, 王欣梦, 杨文智, 钱继红
中国当代儿科杂志 ›› 2021, Vol. 23 ›› Issue (7) : 671-676.
PDF(1057 KB)
PDF(1057 KB)
乳糖酶添加剂对早产儿乳糖不耐受有效性和安全性的前瞻性随机对照研究
Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial
目的 探讨乳糖酶添加剂对改善早产儿乳糖不耐受的有效性和安全性。方法 选取上海交通大学医学院附属新华医院2018年1月至2019年12月收治的有乳糖不耐受症状的早产儿60例纳入研究，随机分为乳糖酶治疗组和对照组，每组30例。乳糖酶治疗组给予乳糖酶添加剂4滴（180 mg）加入早产儿配方奶或母乳中；对照组给予安慰剂，同时予以益生菌（双歧杆菌三联活菌散，喂养后半小时口服，每日2次，每次1 g）和腹部按摩（喂养后1 h脐周顺时针轻柔按摩15 min，每日3次）。在干预后第1周末和第2周末比较两组患儿粪便pH值、粪便还原糖、生长发育、乳糖不耐受症状和实验室指标等情况。结果 乳糖酶治疗组29例、对照组26例完成整个试验。干预后第1周末，乳糖酶治疗组每日吐奶次数和胃潴留量均低于对照组（P < 0.05）；粪便pH值 > 5.0的比例高于对照组（P < 0.05）。干预后第2周末，乳糖酶治疗组每日吐奶次数和24 h腹围差低于对照组（P < 0.05），无胃潴留患儿比例、粪便pH值 > 5.0的比例及粪便还原糖阴性比例均高于对照组（P < 0.05）。研究过程中两组均未发现乳糖酶添加剂或益生菌相关不良反应。结论 乳糖酶添加剂能安全有效地改善早产儿乳糖不耐受引起的临床症状。
Objective To study the efficacy and safety of lactase additive in improving lactose intolerance in preterm infants. Methods A total of 60 preterm infants with lactose intolerance who were admitted to the Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2018 to December 2019 were randomly divided into a lactase treatment group and a control group, with 30 infants in each group. The infants in the lactase treatment group were given 4 drops of lactase additive (180 mg) added into preterm formula or breast milk, and those in the control group were given placebo, oral administration of probiotics (live combined Bifidobacterium, Lactobacillus and Enterococcus powder) at half an hour after feeding (1 g each time, twice a day), and clockwise abdominal massage around the belly button at 1 hour after feeding for 15 minutes each time, 3 times a day. Fecal pH, fecal reducing sugar, growth indicators, symptoms of lactose intolerance, and laboratory markers were measured at the end of the first and second weeks after intervention. Results Finally 29 infants in the lactase treatment group and 26 infants in the control group completed the trial. At the end of the first week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and gastric retention amount (P < 0.05) and a significantly higher proportion of infants with fecal pH > 5.0 (P < 0.05). At the end of the second week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and 24-hour abdominal circumference difference (P < 0.05) and a significantly higher proportion of infants with the absence of gastric retention, fecal pH > 5.0, or negative reducing sugar in feces (P < 0.05). No adverse reactions associated with the lactase additive or probiotics were observed during the trial. Conclusions Lactase additive can safely and effectively improve the clinical symptoms caused by lactose intolerance in preterm infants.
[1] Heine RG, AlRefaee F, Bachina P, et al. Lactose intolerance and gastrointestinal cow's milk allergy in infants and children-common misconceptions revisited[J]. World Allergy Organ J, 2017, 10(1):41. DOI:10.1186/s40413-017-0173-0. PMID:29270244. PMCID:PMC5726035.
[2] Szilagyi A, Ishayek N. Lactose intolerance, dairy avoidance, and treatment options[J]. Nutrients, 2018, 10(12):1994. DOI:10.3390/nu10121994. PMID:30558337. PMC6316316.
[3] 郑直, 虞人杰. 早期新生儿乳糖吸收不良与乳糖不耐受筛查及影响因素探讨[J]. 新生儿科杂志, 2003, 18(6):244-246. DOI:10.3969/j.issn.1673-6710.2003.06.002.
[4] 叶环, 饶燕晓, 徐琛, 等. 住院新生儿乳糖酶缺乏及其体格生长的随访研究[J]. 发育医学电子杂志, 2019, 7(2):115-120. DOI:10.3969/j.issn.2095-5340.2019.02.008.
[5] 中国医师协会新生儿科医师分会循证专业委员会. 新生儿坏死性小肠结肠炎临床诊疗指南(2020)[J]. 中国当代儿科杂志, 2021, 23(1):1-11. DOI:DOI:10.7499/j.issn.1008-8830.2011145. PMID:33476530. PMCID:PMC7818154.
[6] 苏慧敏, 姜毅, 胡玉莲, 等. 新生儿非感染性腹泻乳糖不耐受发生情况调查[J]. 中国当代儿科杂志, 2016, 18(4):306-310. DOI:10.7499/j.issn.1008-8830.2016.04.005. PMID:27097573. PMCID:PMC7390084.
[7] Silberman ES, Jin J. Lactose intolerance[J]. JAMA, 2019, 322(16):1620. DOI:10.1001/jama.2019.9608. PMID:31638683.
[8] Shulman RJ, Wong WW, Smith EO. Influence of changes in lactase activity and small-intestinal mucosal growth on lactose digestion and absorption in preterm infants[J]. Am J Clin Nutr, 2005, 81(2):472-479. DOI:10.1093/ajcn.81.2.472. PMID:15699237.
[9] Heyman MB, Committee on Nutrition. Lactose intolerance in infants, children, and adolescents[J]. Pediatrics, 2006, 118(3):1279-1286. DOI:10.1542/peds.2006-1721. PMID:16951027.
[10] Vandenplas Y. Lactose intolerance[J]. Asia Pac J Clin Nutr, 2015, 24(Suppl 1):S9-S13. DOI:10.6133/apjcn.2015.24.s1.02. PMID:26715083.
[11] Griffin MP, Hansen JW. Can the elimination of lactose from formula improve feeding tolerance in premature infants?[J]. J Pediatr, 1999, 135(5):587-592. DOI:10.1016/s0022-3476(99)70057-0. PMID:10547247.
[12] Szajewska H. Extensive and partial protein hydrolysate preterm formulas[J]. J Pediatr Gastroenterol Nutr, 2007, 45(Suppl 3):S183-S187. DOI:10.1097/01.mpg.0000302969.60373.39. PMID:18185089.
[13] 余慕雪, 庄思齐, 王丹华, 等. 深度水解蛋白配方乳对早产儿喂养和生长影响的多中心临床对照研究[J]. 中国当代儿科杂志, 2014, 16(7):684-690. DOI:10.7499/j.issn.1008-8830.2014.07.006. PMID:25008873.
[14] 侯德红, 张琳, 丁雪晶, 等. 深度水解蛋白配方奶对早产低体重儿喂养疗效观察[J]. 中国实用儿科杂志, 2014, 29(11):874-876. DOI:10.7504/ek2014110618.
[15] Misselwitz B, Butter M, Verbeke K, et al. Update on lactose malabsorption and intolerance:pathogenesis, diagnosis and clinical management[J]. Gut, 2019, 68(11):2080-2091. DOI:10.1136/gutjnl-2019-318404. PMID:31427404. PMCID:PMC6839734.
[16] Erasmus HD, Ludwig-Auser HM, Paterson PG, et al. Enhanced weight gain in preterm infants receiving lactase-treated feeds:a randomized, double-blind, controlled trial[J]. J Pediatr, 2002, 141(4):532-537. DOI:10.1067/mpd.2002.127499. PMID:12378193.
[17] 石壮, 翁志媛, 张又祥. 添加乳糖酶与无乳糖奶粉喂养治疗婴幼儿乳糖不耐受的效果对比[J]. 中国当代医药, 2019, 26(14):104-107. DOI:10.3969/j.issn.1674-4721.2019.14.031.
[18] Pereira-da-Silva L, Dias MP, Virella D, et al. Osmolality of preterm formulas supplemented with nonprotein energy supplements[J]. Eur J Clin Nutr, 2008, 62(2):274-278. DOI:10.1038/sj.ejcn.1602736. PMID:17375112.
[19] Ugidos-Rodríguez S, Matallana-González MC, Sánchez-Mata MC. Lactose malabsorption and intolerance:a review[J]. Food Funct, 2018, 9(8):4056-4068. DOI:10.1039/c8fo00555a. PMID:29999504.
[20] Hodges JK, Cao SS, Cladis DP, et al. Lactose intolerance and bone health:the challenge of ensuring adequate calcium intake[J]. Nutrients, 2019, 11(4):718. DOI:10.3390/nu11040718. PMID:30925689. PMCID:PMC6521087.
